首页|运用外部质量评估数据评价实验室血糖、糖化血红蛋白检测结果的质量策略

运用外部质量评估数据评价实验室血糖、糖化血红蛋白检测结果的质量策略

扫码查看
目的 利用外部质量评估(EQA)数据,建立适合血糖(GLU)、糖化血红蛋白(HbA1c)大数据研究的质量评价策略,保证大数据研究成果的有效性.方法 对参加国家卫健委临检中心EQA活动的GLU和HbA1c数据进行回顾性分析,与基于生物学变异(BV)的不同等级质量标准进行比较,计算实验室GLU和HbA1c EQAs的接受率和绝对百分比偏倚,建立适合GLU和HbA1c的质量策略.结果 GLU和HbA1c EQAs接受率差异较大,0.00%~100.00%不等.满足GLU和HbA1c最佳、适当和最低标准的平均绝对百分比偏移分别为0.61%、1.00%、1.21%和0.29%、0.60%、0.76%.结论 GLU和HbA1c EQAs接受率和不同质量等级的EQAs结果差异有统计学意义.EQA是最低质量标准,即使通过了 EQA评价,也不能保证实验室测试结果适合大数据研究的质量要求.EQA可以作为构建大数据研究的参考指南.
The Quality Strategy for Evaluating Laboratory Blood Glucose and Glycated Hemoglobin Results Using External Quality Assessment Survey Data
Objective Using External Quality Assessment(EQA)data,to establish a quality evaluation strategy suitable for the study of blood glucose(GLU)and glycated hemoglobin(HbA1c)based on big dataset.Methods A retrospective analysis of GLU and HbA1c EQA data participating in the EQA program of the National Health Commission was conducted.Acceptance rate and absolute percentage bias for GLU and HbA1c were calculated according to the biological variant(BV)quality specification,and we further established a quality strategy suitable for GLU and HbA1c.Results The acceptance rate of GLU and HbA1c were different.The GLU and HbA1c EQAs acceptance rates varied greatly,ranging from 0.00%to 100.00%.The mean percentage biases were 0.61%,1.00%,1.21%and 0.29%,0.60%,0.76%for GLU and HbA1c,respectively,which satisfied optimum,desirable,and minimum criteria.Conclusion The acceptance rate of GLU and HbA1c of different quality levels and the results of EQA are significantly different.The EQA is shown to be the lowest quality standard.Although it passes the EQA standard,this approach cannot guarantee that the laboratory test results are suitable for the quality requirements of big data research.The EQA can serve as a reference guide for the construction of big data studies.

GlucoseGlycated hemoglobinExternal quality assessmentBiasBiological variationQuality standard

孔丽蕊、刘燕群、吴风、何大海、黄英、周朝琼、张艳

展开 >

成都市郫都区中医医院检验科,四川成都 611730

成都中医药大学附属第三医院检验科,四川成都 610031

血糖 糖化血红蛋白 外部质量评估 偏移 生物学变异 质量标准

2024

标记免疫分析与临床
中国同辐股份有限公司

标记免疫分析与临床

CSTPCD
影响因子:0.978
ISSN:1006-1703
年,卷(期):2024.31(11)